FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015940002> ?p ?o ?g. }

• W2015940002 endingPage "465" @default.
• W2015940002 startingPage "457" @default.
• W2015940002 abstract "Dabigatran and rivaroxaban have recently been added to the armamentarium for thromboprophylaxis in orthopedic surgery. Although this is their first licensed indication, others will soon follow. Owing to their claimed predictable anticoagulant response that dispenses with the need for monitoring coagulation, their effects are poorly described in routine cases. However, interpreting blood coagulation results and evaluating whether a treatment is properly targeted in the case of untoward incidents will become a common concern for clinicians.Eighty patients undergoing total hip or knee replacement were included in two studies. Forty of them received dabigatran (study 1) and 40 rivaroxaban (study 2). Blood samples (n = 176 and 166) were taken preoperatively and twice a week from the first postoperative day.Dabigatran increased aPTTr about two-fold and PT about 1.2-fold, and it was mostly an initiation-phase modulator of thrombin generation. Mean circulating concentrations as measured by a diluted thrombin time were 105 ± 85 ng/mL at T(max) in samples from patients receiving the full dosing. They depended significantly on renal function, body weight and gender. Rivaroxaban increased aPTTr and PTr around 1.5 fold and modified the initiation and amplification phases of thrombin generation, with a lowered and prolonged thrombin burst. Mean circulating concentrations as measured by an antiXa test were 117 ± 78 ng/mL at T(max). With both drugs, routine coagulation tests, thrombin generation curves and functionally determined concentrations exhibited high interindividual variability.Routine coagulation tests are altered in patients receiving dabigatran or rivaroxaban, but their alterations poorly reflect the circulating concentrations as determined by functional approaches." @default.
• W2015940002 created "2016-06-24" @default.
• W2015940002 creator A5024030529 @default.
• W2015940002 creator A5036145715 @default.
• W2015940002 creator A5074967889 @default.
• W2015940002 creator A5088220257 @default.
• W2015940002 date "2011-05-01" @default.
• W2015940002 modified "2023-10-18" @default.
• W2015940002 title "Coagulation parameters in patients receiving dabigatran etexilate or rivaroxaban: Two observational studies in patients undergoing total hip or total knee replacement" @default.
• W2015940002 cites W1559861101 @default.
• W2015940002 cites W1969218311 @default.
• W2015940002 cites W1975116009 @default.
• W2015940002 cites W1986121502 @default.
• W2015940002 cites W1989930316 @default.
• W2015940002 cites W1999385881 @default.
• W2015940002 cites W1999948625 @default.
• W2015940002 cites W2000438765 @default.
• W2015940002 cites W2014491911 @default.
• W2015940002 cites W2016541949 @default.
• W2015940002 cites W2031581415 @default.
• W2015940002 cites W2035193897 @default.
• W2015940002 cites W2036506340 @default.
• W2015940002 cites W2037541016 @default.
• W2015940002 cites W2045987573 @default.
• W2015940002 cites W2058161894 @default.
• W2015940002 cites W2060578439 @default.
• W2015940002 cites W2062696489 @default.
• W2015940002 cites W2062946016 @default.
• W2015940002 cites W2064012881 @default.
• W2015940002 cites W2086443301 @default.
• W2015940002 cites W2096632920 @default.
• W2015940002 cites W2113446992 @default.
• W2015940002 cites W2115348966 @default.
• W2015940002 cites W2124882231 @default.
• W2015940002 cites W2145112089 @default.
• W2015940002 cites W2150567120 @default.
• W2015940002 cites W2157224841 @default.
• W2015940002 doi "https://doi.org/10.1016/j.thromres.2011.01.001" @default.
• W2015940002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21277622" @default.
• W2015940002 hasPublicationYear "2011" @default.
• W2015940002 type Work @default.
• W2015940002 sameAs 2015940002 @default.
• W2015940002 citedByCount "146" @default.
• W2015940002 countsByYear W20159400022012 @default.
• W2015940002 countsByYear W20159400022013 @default.
• W2015940002 countsByYear W20159400022014 @default.
• W2015940002 countsByYear W20159400022015 @default.
• W2015940002 countsByYear W20159400022016 @default.
• W2015940002 countsByYear W20159400022017 @default.
• W2015940002 countsByYear W20159400022018 @default.
• W2015940002 countsByYear W20159400022019 @default.
• W2015940002 countsByYear W20159400022020 @default.
• W2015940002 countsByYear W20159400022021 @default.
• W2015940002 countsByYear W20159400022022 @default.
• W2015940002 countsByYear W20159400022023 @default.
• W2015940002 crossrefType "journal-article" @default.
• W2015940002 hasAuthorship W2015940002A5024030529 @default.
• W2015940002 hasAuthorship W2015940002A5036145715 @default.
• W2015940002 hasAuthorship W2015940002A5074967889 @default.
• W2015940002 hasAuthorship W2015940002A5088220257 @default.
• W2015940002 hasConcept C126322002 @default.
• W2015940002 hasConcept C141071460 @default.
• W2015940002 hasConcept C16124881 @default.
• W2015940002 hasConcept C2776301958 @default.
• W2015940002 hasConcept C2776710957 @default.
• W2015940002 hasConcept C2777288759 @default.
• W2015940002 hasConcept C2777292125 @default.
• W2015940002 hasConcept C2778104916 @default.
• W2015940002 hasConcept C2778205648 @default.
• W2015940002 hasConcept C2778382381 @default.
• W2015940002 hasConcept C2778661090 @default.
• W2015940002 hasConcept C2778810321 @default.
• W2015940002 hasConcept C2779161974 @default.
• W2015940002 hasConcept C3018972837 @default.
• W2015940002 hasConcept C42219234 @default.
• W2015940002 hasConcept C68312169 @default.
• W2015940002 hasConcept C71924100 @default.
• W2015940002 hasConcept C89560881 @default.
• W2015940002 hasConceptScore W2015940002C126322002 @default.
• W2015940002 hasConceptScore W2015940002C141071460 @default.
• W2015940002 hasConceptScore W2015940002C16124881 @default.
• W2015940002 hasConceptScore W2015940002C2776301958 @default.
• W2015940002 hasConceptScore W2015940002C2776710957 @default.
• W2015940002 hasConceptScore W2015940002C2777288759 @default.
• W2015940002 hasConceptScore W2015940002C2777292125 @default.
• W2015940002 hasConceptScore W2015940002C2778104916 @default.
• W2015940002 hasConceptScore W2015940002C2778205648 @default.
• W2015940002 hasConceptScore W2015940002C2778382381 @default.
• W2015940002 hasConceptScore W2015940002C2778661090 @default.
• W2015940002 hasConceptScore W2015940002C2778810321 @default.
• W2015940002 hasConceptScore W2015940002C2779161974 @default.
• W2015940002 hasConceptScore W2015940002C3018972837 @default.
• W2015940002 hasConceptScore W2015940002C42219234 @default.
• W2015940002 hasConceptScore W2015940002C68312169 @default.
• W2015940002 hasConceptScore W2015940002C71924100 @default.
• W2015940002 hasConceptScore W2015940002C89560881 @default.
• W2015940002 hasIssue "5" @default.
• W2015940002 hasLocation W20159400021 @default.

• next